Oppenheimer Adjusts Biogen (NASDAQ:BIIB) Price Target to $350 From $325By legume / May 23, 2023 / Biogen, Oppenheimer Oppenheimer Adjusts Biogen (NASDAQ:BIIB) Price Target to $350 From $325, Maintains Outperform Rating.